| Year |
Citation |
Score |
| 2023 |
Syed Mohammed RD, Piell KM, Maurer MC. Identification of Factor XIII β-sandwich residues mediating glutamine substrate binding and activation peptide cleavage. Thrombosis and Haemostasis. PMID 38040030 DOI: 10.1055/a-2220-7544 |
0.511 |
|
| 2023 |
Ablan FDO, Maurer MC. Fbg αC 389-402 Enhances Factor XIII Cross-Linking in the Fibrinogen αC Region Via Electrostatic and Hydrophobic Interactions. Biochemistry. 62: 2170-2181. PMID 37410946 DOI: 10.1021/acs.biochem.3c00066 |
0.322 |
|
| 2022 |
Syed Mohammed RD, Ablan FDO, McCann NM, Hindi MM, Maurer MC. Transglutaminase Activities of Blood Coagulant Factor XIII are Dependent on the Activation Pathways and on the Substrates. Thrombosis and Haemostasis. PMID 36473493 DOI: 10.1055/a-1993-4193 |
0.505 |
|
| 2020 |
Dean O. Ablan F, McCann NM, Hindi MM, Maurer MC. Effect of Binding Site Mutations in Fibrinogen αC (233-425) On FXIII Substrate Specificity Biophysical Journal. 118: 532a. DOI: 10.1016/J.Bpj.2019.11.2917 |
0.375 |
|
| 2020 |
Syed Mohammed RDA, Butala H, Maurer M. Activity and Substrate Specificity of Factor XIII Resulting from Different Activation Pathways Biophysical Journal. 118: 531a. DOI: 10.1016/J.Bpj.2019.11.2912 |
0.414 |
|
| 2019 |
Anokhin BA, Dean WL, Smith KA, Flick MJ, Ariëns RAS, Philippou H, Maurer MC. Proteolytic and Nonproteolytic Activation Mechanisms Result in Conformationally and Functionally Different Forms of Coagulation Factor XIII A. The Febs Journal. PMID 31407850 DOI: 10.1111/Febs.15040 |
0.484 |
|
| 2019 |
Mouapi KN, Wagner LJ, Stephens CA, Hindi MM, Wilkey DW, Merchant ML, Maurer MC. Evaluating the Effects of Fibrinogen αC Mutations on the Ability of Factor XIII to Crosslink the Reactive αC Glutamines (Q237, Q328, Q366). Thrombosis and Haemostasis. PMID 31055797 DOI: 10.1055/S-0039-1687875 |
0.399 |
|
| 2019 |
Billur R, Sabo TM, Maurer MC. Thrombin Exosite Maturation and Ligand Binding at ABE II Help Stabilize PAR-Binding Competent Conformation at ABE I. Biochemistry. PMID 30672691 DOI: 10.1021/Acs.Biochem.8B00943 |
0.467 |
|
| 2018 |
Li B, Billur R, Maurer MC, Kohler HP, Raddatz Müller P, Alberio L, Schroeder V. Proline 36 of the Factor XIII Activation Peptide Plays a Crucial Role in Substrate Recognition and Zymogen Activation. Thrombosis and Haemostasis. PMID 30419598 DOI: 10.1055/S-0038-1675600 |
0.613 |
|
| 2018 |
Hethershaw EL, Adamson PJ, Smith KA, Goldsberry WN, Pease RJ, Radford SE, Grant PJ, Ariëns RAS, Maurer MC, Philippou H. The role of barrels 1 and 2 in the enzymatic activity of factor XIII-A. Journal of Thrombosis and Haemostasis : Jth. PMID 29675848 DOI: 10.1111/Jth.14128 |
0.453 |
|
| 2018 |
Billur R, Michael Sabo T, Maurer MC. Evaluating How Binding Interactions for PARs Change as Prothrombin is Converted to Thrombin Biophysical Journal. 114: 67a. DOI: 10.1016/J.Bpj.2017.11.416 |
0.335 |
|
| 2017 |
Billur R, Ban D, Sabo TM, Maurer MC. Deciphering Conformational Changes Associated with the Maturation of Thrombin Anion Binding Exosite I. Biochemistry. PMID 29111672 DOI: 10.1021/Acs.Biochem.7B00970 |
0.462 |
|
| 2017 |
Anokhin BA, Stribinskis V, Dean WL, Maurer MC. Activation of Factor XIII is Accompanied by a Change in Oligomerization State. The Febs Journal. PMID 28915348 DOI: 10.1111/Febs.14272 |
0.495 |
|
| 2017 |
Jadhav MA, Goldsberry WN, Zink SE, Lamb KN, Simmons KE, Riposo CM, Anokhin BA, Maurer MC. Screening Cleavage of Factor XIII V34X Activation Peptides by Thrombin Mutants: A Strategy for Controlling Fibrin Architecture. Biochimica Et Biophysica Acta. PMID 28687225 DOI: 10.1016/J.Bbapap.2017.07.001 |
0.574 |
|
| 2016 |
Mouapi KN, Bell JD, Smith KA, Ariëns RA, Philippou H, Maurer MC. Ranking reactive glutamines in the fibrinogen αC region that are targeted by blood coagulant Factor XIII. Blood. PMID 26951791 DOI: 10.1182/Blood-2015-09-672303 |
0.43 |
|
| 2016 |
Njine Mouapi K, Smith KA, Ariens RA, Philippou H, Maurer MC. Transglutaminase Factor XIII Cross-Links Reactive Glutamines in Disordered Regions of Fibrinogen αC Biophysical Journal. 110: 549a. DOI: 10.1016/J.Bpj.2015.11.2935 |
0.452 |
|
| 2016 |
Billur R, Maurer MC. Anion Binding Exosites as a Target to Understand the Activation of Thrombin Biophysical Journal. 110: 220a. DOI: 10.1016/J.Bpj.2015.11.1221 |
0.464 |
|
| 2015 |
Billur R, Malovichko MV, Maurer MC. Ligand Binding to Anion Binding Exosites as Prothrombin is Converted to Active Thrombin Biophysical Journal. 108: 531a. DOI: 10.1016/J.Bpj.2014.11.2913 |
0.398 |
|
| 2015 |
Mouapi KN, Bell J, Smith K, Philippou H, Ariens R, Maurer M. Probing Factor XIII Substrate Specificity for Fibrinogen αC (233-425) Using Maldi-Tof Mass Spectrometry and 2D 15N-1H HSQC NMR Spectroscopy Biophysical Journal. 108: 531a. DOI: 10.1016/J.Bpj.2014.11.2912 |
0.46 |
|
| 2014 |
Doiphode PG, Malovichko MV, Mouapi KN, Maurer MC. Evaluating factor XIII specificity for glutamine-containing substrates using a matrix-assisted laser desorption/ionization time-of-flight mass spectrometry assay. Analytical Biochemistry. 457: 74-84. PMID 24751466 DOI: 10.1016/J.Ab.2014.04.014 |
0.727 |
|
| 2014 |
Maurer M, Malovichko M. Monitoring Conformational Changes that Occur to Blood Coagulant Prothrombin as it is Activated to Thrombin Biophysical Journal. 106: 676a-677a. DOI: 10.1016/J.Bpj.2013.11.3747 |
0.412 |
|
| 2013 |
Malovichko MV, Sabo TM, Maurer MC. Ligand binding to anion-binding exosites regulates conformational properties of thrombin. The Journal of Biological Chemistry. 288: 8667-78. PMID 23378535 DOI: 10.1074/Jbc.M112.410829 |
0.418 |
|
| 2012 |
Maurer M, Woofter R. Mapping the Oligomeric Assembly of Plasma Factor XIII A2B2 by Hydrogen-Deuterium Exchange Coupled with MALDI-TOF Mass Spectrometry Biophysical Journal. 102: 462a. DOI: 10.1016/J.Bpj.2011.11.2534 |
0.33 |
|
| 2011 |
Jadhav MA, Lucas RC, Goldsberry WN, Maurer MC. Design of Factor XIII V34X activation peptides to control ability to interact with thrombin mutants. Biochimica Et Biophysica Acta. 1814: 1955-63. PMID 21798378 DOI: 10.1016/J.Bbapap.2011.07.012 |
0.621 |
|
| 2011 |
Maurer MC. Switching cation-binding loops paves the way for redesigning allosteric activation. Proceedings of the National Academy of Sciences of the United States of America. 108: 5145-6. PMID 21415371 DOI: 10.1073/Pnas.1102132108 |
0.365 |
|
| 2010 |
Jadhav MA, Isetti G, Trumbo TA, Maurer MC. Effects of introducing fibrinogen Aalpha character into the factor XIII activation peptide segment. Biochemistry. 49: 2918-24. PMID 20218626 DOI: 10.1021/Bi902127U |
0.808 |
|
| 2009 |
Cleary DB, Doiphode PG, Sabo TM, Maurer MC. A non-reactive glutamine residue of alpha2-antiplasmin promotes interactions with the factor XIII active site region. Journal of Thrombosis and Haemostasis : Jth. 7: 1947-9. PMID 19691486 DOI: 10.1111/J.1538-7836.2009.03583.X |
0.73 |
|
| 2009 |
Sabo TM, Maurer MC. Biophysical investigation of GpIbalpha binding to thrombin anion binding exosite II. Biochemistry. 48: 7110-22. PMID 19591434 DOI: 10.1021/Bi900745B |
0.491 |
|
| 2007 |
Sabo TM, Brasher PB, Maurer MC. Perturbations in factor XIII resulting from activation and inhibition examined by solution based methods and detected by MALDI-TOF MS. Biochemistry. 46: 10089-101. PMID 17691819 DOI: 10.1021/Bi700579Z |
0.447 |
|
| 2007 |
Isetti G, Maurer MC. Employing mutants to study thrombin residues responsible for factor XIII activation peptide recognition: a kinetic study. Biochemistry. 46: 2444-52. PMID 17286389 DOI: 10.1021/Bi0622120 |
0.809 |
|
| 2006 |
Cleary DB, Maurer MC. Characterizing the specificity of activated Factor XIII for glutamine-containing substrate peptides. Biochimica Et Biophysica Acta. 1764: 1207-17. PMID 16820332 DOI: 10.1016/J.Bbapap.2006.05.003 |
0.766 |
|
| 2006 |
Sabo TM, Farrell DH, Maurer MC. Conformational analysis of gamma' peptide (410-427) interactions with thrombin anion binding exosite II. Biochemistry. 45: 7434-45. PMID 16768439 DOI: 10.1021/Bi060360K |
0.589 |
|
| 2006 |
Maurer MC, Trumbo TA, Isetti G, Turner BT. Probing interactions between the coagulants thrombin, Factor XIII, and fibrin(ogen). Archives of Biochemistry and Biophysics. 445: 36-45. PMID 16364233 DOI: 10.1016/J.Abb.2005.11.009 |
0.808 |
|
| 2004 |
Turner BT, Sabo TM, Wilding D, Maurer MC. Mapping of factor XIII solvent accessibility as a function of activation state using chemical modification methods. Biochemistry. 43: 9755-65. PMID 15274630 DOI: 10.1021/Bi049260+ |
0.449 |
|
| 2004 |
Isetti G, Maurer MC. Thrombin activity is unaltered by N-terminal truncation of factor XIII activation peptides. Biochemistry. 43: 4150-9. PMID 15065858 DOI: 10.1021/Bi049796V |
0.826 |
|
| 2004 |
Isetti G, Maurer MC. Probing thrombin's ability to accommodate a V34F substitution within the factor XIII activation peptide segment (28-41). The Journal of Peptide Research : Official Journal of the American Peptide Society. 63: 241-52. PMID 15049836 DOI: 10.1111/J.1399-3011.2004.00132.X |
0.82 |
|
| 2003 |
Trumbo TA, Maurer MC. V34I and V34A substitutions within the factor XIII activation peptide segment (28-41) affect interactions with the thrombin active site. Thrombosis and Haemostasis. 89: 647-53. PMID 12669118 DOI: 10.1055/S-0037-1613570 |
0.656 |
|
| 2003 |
Cleary DB, Ehringer WD, Maurer MC. Establishing the inhibitory effects of bradykinin on thrombin. Archives of Biochemistry and Biophysics. 410: 96-106. PMID 12559981 DOI: 10.1016/S0003-9861(02)00677-X |
0.752 |
|
| 2002 |
Marinescu A, Cleary DB, Littlefield TR, Maurer MC. Structural features associated with the binding of glutamine-containing peptides to Factor XIII. Archives of Biochemistry and Biophysics. 406: 9-20. PMID 12234485 DOI: 10.1016/S0003-9861(02)00407-1 |
0.812 |
|
| 2002 |
Cleary DB, Trumbo TA, Maurer MC. Protease-activated receptor 4-like peptides bind to thrombin through an optimized interaction with the enzyme active site surface. Archives of Biochemistry and Biophysics. 403: 179-88. PMID 12139967 DOI: 10.1016/S0003-9861(02)00220-5 |
0.821 |
|
| 2002 |
Turner BT, Maurer MC. Evaluating the roles of thrombin and calcium in the activation of coagulation factor XIII using H/D exchange and MALDI-TOF MS. Biochemistry. 41: 7947-54. PMID 12069584 DOI: 10.1021/Bi025630N |
0.4 |
|
| 2002 |
Trumbo TA, Maurer MC. Thrombin hydrolysis of V29F and V34L mutants of factor XIII (28-41) reveals roles of the P(9) and P(4) positions in factor XIII activation. Biochemistry. 41: 2859-68. PMID 11851434 DOI: 10.1021/Bi0157823 |
0.632 |
|
| 2000 |
Trumbo TA, Maurer MC. Examining thrombin hydrolysis of the Factor XIII activation peptide segment leads to a proposal for explaining the cardioprotective effects observed with the Factor XIII V34L mutation Journal of Biological Chemistry. 275: 20627-20631. PMID 10801785 DOI: 10.1074/Jbc.M000209200 |
0.547 |
|
| 1999 |
Maurer MC, Trosset JY, Lester CC, DiBella EE, Scheraga HA. New general approach for determining the solution structure of a ligand bound weakly to a receptor: structure of a fibrinogen Aalpha-like peptide bound to thrombin (S195A) obtained using NOE distance constraints and an ECEPP/3 flexible docking program. Proteins. 34: 29-48. PMID 10336381 DOI: 10.1002/(Sici)1097-0134(19990101)34:1<29::Aid-Prot4>3.0.Co;2-U |
0.38 |
|
| 1998 |
Maurer MC, Peng JL, An SS, Trosset JY, Henschen-Edman A, Scheraga HA. Structural examination of the influence of phosphorylation on the binding of fibrinopeptide A to bovine thrombin. Biochemistry. 37: 5888-902. PMID 9558322 DOI: 10.1021/Bi972538W |
0.451 |
|
| 1995 |
DiBella EE, Maurer MC, Scheraga HA. Expression and folding of recombinant bovine prethrombin-2 and its activation to thrombin. The Journal of Biological Chemistry. 270: 163-9. PMID 7814368 DOI: 10.1074/Jbc.270.1.163 |
0.309 |
|
| Show low-probability matches. |